Winship Logo

Clinical Trial Details

Back to clinical trials
Phase N/AInterventional

Behavioral Parenting Skills as a Novel Target for Improving Pediatric Medication Adherence: Study 3

Protocol: STUDY00007809NCT: NCT06074666

Overview

The current study will assess the acceptability and feasibility of the CareMeds intervention with a larger sample (N = 100) across multiple sites in Buffalo, NY, and Atlanta, GA.

Eligibility

Ages3 Years - 9 Years
SexAll
Healthy VolunteersNo
Age GroupsChild

Inclusion Criteria:

  • Parent of a child who is diagnosed and being treated for any type of acute lymphoblastic leukemia (ALL) at a study site.
  • Parent has primary medication responsibility.
  • Pediatric patient aged 3-9 years
  • Child on therapy that includes home-based oral anti-cancer medication, such as 6-MP.
  • Parent has verbal English or Spanish fluency.
  • Participant must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure

Exclusion Criteria:

  • Parent is unwilling or unable to follow protocol requirements
Investigators
SC
Sharon Castellino
View on ClinicalTrials.gov